Ultrasensitive Blood Biomarker Detection for Precision Health and Research June 3 | 11:30 AM – 1:30 PM | Mount Sinai Hospital 1468 Madison Ave, New York, NY 10029 Annenberg Building, 20th Floor – Conference Room 20-01 +++++++

https://www.quanterix.com/conferences/simoa-roadshow-mt-sinai-jun-2025-registration/?utm_source=pardot&utm_medium=email&utm_campaign=may20_newsletter Discover How to Achieve High Sensitivity Cytokine Biomarker Quantification in Complex Samples Using Simoa Assays date June 11, 2025 time & location 11:30AM ET, Virtual https://www.quanterix.com/webinars/discover-how-to-achieve-high-sensitivity-cytokine-biomarker-quantification-in-complex-samples-using-simoa-assays/?utm_source=pardot&utm_medium=email&utm_campaign=may20_newsletter Alzheimer’s Association International Conference® 2025 date July 27-31, 2025 location Toronto, Canada https://www.quanterix.com/conferences/alzheimers-association-international-conference-2025/?utm_source=pardot&utm_medium=email&utm_campaign=may20_newsletter The Evolution of IFN-α Measurement: How Simoa® is Driving New Breakthroughs https://www.quanterix.com/blog-the-evolution-of-ifn-a-measurement-how-simoa-is-driving-new-breakthroughs/?utm_source=pardot&utm_medium=email&utm_campaign=may20_newsletter Breakthroughs in IFN-α Detection https://go.quanterix.com/publication-brief-immunology-ifna May is National Arthritis Awareness Month, drawing attention to the need for research, education, and improved care for the millions affected by autoimmune and inflammatory joint diseases. As part of this mission, scientists are turning to cytokine biomarkers, especially type I interferons like IFN-α, to better understand the molecular drivers of diseases such as systemic lupus erythematosus and systemic juvenile idiopathic arthritis. In this edition, we spotlight a recent study using the Simoa® technology to directly quantify IFN-α in pediatric patients. This work not only advances our understanding of interferon biology but also supports efforts to refine diagnostic tools and therapeutic strategies for arthritis and related autoinflammatory disorders. Direct IFN-α2 Quantification in Pediatric Autoimmune Diseases Using Simoa® and Transcriptomic Profiling https://www.quanterix.com/blog-direct-ifn-a2-quantification-in-pediatric-autoimmune-diseases-using-simoa-and-transcriptomic-profiling/?utm_source=pardot&utm_medium=email&utm_campaign=may20_newsletter Interferon-alpha (IFN-α), Multi-Subtype https://www.quanterix.com/simoa-assay-kits/interferon-alpha-ifn-%CE%B1-ms/